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a b s t r a c t
Objective: To measure the effect of occlusal splints as an additional treatment on psycho-
logical aspects in temporomandibular disorder patients.
Design: A randomized controlled trial was performed comprising 60 adults diagnosed with
masticatory myofascial pain according the Research Diagnostic Criteria for Temporoman-
dibular Disorders (RDC/TMD). The participants were divided equally into 2 treatment
groups, which received only counselling (Group 1) or occlusal splints in addition to coun-
selling (Group 2). The assessments occurred at baseline and at 2 and 5 months after
treatment. The outcomes were symptoms of anxiety and depression, as well as pain
catastrophizing. Two-way ANOVA, Friedman and Mann–Whitney tests were used to per-
form the statistical analysis, considering a significance level of 5%.
Results: In relation to the baseline assessment, 60% of the subjects had at least mild anxiety
and 25% had at least mild depression, and the mean and standard deviation (SD) of pain
catastrophizing was 2.41 (1.33) for Group 1 and 2.06 (1.04) for Group 2. Comparisons between
baseline and the fifth-month evaluation showed an improvement in anxiety and depression
symptoms only in Group 2 ( p < 0.05). Otherwise, there was a significant reduction in pain
catastrophizing in both groups ( p < 0.05), with a mean (SD) of 1.14 (1.28) for Group 1 and 0.76
(0.82) for Group 2.
Conclusion: Minimally invasive strategies could provide an improvement in the psychologi-
cal aspects of temporomandibular disorder patients, and the use of an occlusal splint seems
to hasten the manifestation of these effects.
# 2015 Elsevier Ltd. All rights reserved.
* Corresponding author at: Department of Prosthodontics, Bauru School of Dentistry, University of Sa˜o Paulo, Al. Octa´vio Pinheiro Brizolla
9-75, CEP 17012-901 Vila Universita´ria, Bauru, SP, Brazil. Tel.: +55 14 3235 8000.
E-mail addresses: yurimartinscosta@yahoo.com.br, yuricosta@usp.br (Y.M. Costa).
Available online at www.sciencedirect.com
ScienceDirect
journal homepage: http://www.elsevier.com/locate/aobhttp://dx.doi.org/10.1016/j.archoralbio.2015.02.005
0003–9969/# 2015 Elsevier Ltd. All rights reserved.
a r c h i v e s o f o r a l b i o l o g y 6 0 ( 2 0 1 5 ) 7 3 8 – 7 4 4 7391. Introduction
The definition of pain according to the International Associa-
tion for the Study of Pain (IASP) emphasizes the importance of
emotional and psychological constituents. Hence, rather than
a purely physiological and sensorial response, pain is
understood as a personal experience involving more than
just biological aspects.1 Understanding the influence of these
emotional and psychological aspects of pain perception
entails a conceptual change from the biomedical to the
biopsychosocial model, which embraces the multidimension-
ality of the pain experience and highlights the role of
emotional and behavioural aspects.2
Among the pain-related conditions associated with psy-
chological factors, temporomandibular disorder (TMD) stands
out in particular and is defined as an umbrella of clinical
conditions affecting the masticatory muscles, the temporo-
mandibular joint (TMJ) and associated structures.3 There is
evidence of muscle pain associated with stress, as well as
higher anxiety and depression levels when comparing TMD
subjects with asymptomatic controls.4–6 Furthermore, TMD
diagnosis can be associated with psychological distress and
with higher levels of pain catastrophizing (negative and
amplified thoughts involving a noxious stimulus).7,8 All of
these factors endorse the relevance of the biopsychosocial
model of pain.
It is known that some psychosocial characteristics or
psychological profiles can predispose people to TMD develop-
ment.9,10 This possible causal relationship is borne out by the
analysis of exclusively psychological management strategies
that reduce pain intensity in this population.11 Otherwise, in a
chronic state, pain itself could aggravate or contribute to
psychosocial or psychological distress, generating a vicious
cycle.12
Thus, it can be expected that management approaches to
control TMD pain could have some benefit on psychological
factors. Minimally invasive strategies, like an occlusal splint or
patient counselling, are well established and show strong
evidence of a reduction in pain intensity and muscle
sensitivity.13 Nonetheless, little is known about their effect
on psychological factors, like anxiety, depression and cata-
strophizing. It is also well accepted that there are other
explanations related to central mechanisms that enhance the
efficacy of occlusal splints, apart from the peripheral and so-
called ‘‘occlusal effects’’ of these splints, e.g. cognitive
awareness and placebo.14 This influence on higher-order
central processing could be related to the improvement of
psychological aspects. Furthermore, in a recent systematic
review, de Freitas et al.15 stated that counselling and self-
management-based therapies could improve psychological
aspects and reduce harmful behaviour in TMD subjects. In this
scenario, an interesting question arises: considering the
potential psychological effects of the occlusal splint, does it
have an additional benefit on improving psychological aspects
beyond counselling and a self-management strategy?
Based on this question, the aims of this study were: (1) to
measure and (2) compare the effect of two minimally invasive
strategies on symptoms of anxiety and depression and pain
catastrophizing levels in subjects with masticatory myofascialpain. The null hypotheses were: (1) there is no improvement in
certain psychological factors after 5 months of treatment and
(2) there is no difference between the two strategies/
treatments.
2. Material and methods
2.1. Sample
This study consisted of a randomized controlled trial conducted
in Brazil, performed in accordance with the ethical standards of
the Declaration of Helsinki and its later amendments, and
approved by the Human Research Ethics Committee of the
Bauru School of Dentistry, University of Sao Paulo.
The study was conducted at the Orofacial Pain Clinic of the
Bauru School of Dentistry from August 2011 to April 2013, and
the participants were recruited from the local community
through advertisements. Eligible subjects included adults 18–
50 years of age, who met the criteria for myofascial pain
according to the Research Diagnostic Criteria for Temporo-
mandibular Disorders (RDC/TMD),16 with pain duration of at
least 3 months. Exclusion criteria included: occlusal risk
factors for temporomandibular disorders17; history of head
trauma, intracranial disorders, vascular disorders and other
major causes of headache, other than temporomandibular
joint disorders, listed in the International Classification of
Headache Disorders (ICDH II)18; use of medications like muscle
relaxants, anticonvulsants, antidepressants and anxiolytics;
other causes of orofacial pain, like caries, periodontal disease
or atypical odontalgia, fibromyalgia, chief complaint of
headache, temporomandibular joint pain and TMD manage-
ment performed in the last 3 months. The sample size was
determined by considering a dropout rate of 25% and a mean
(SD) difference of 2 (1.5) on the pain catastrophizing scale, with
a power of 90% and a two-sided significance level of 5%.
2.2. Treatment
All subjects selected (n = 60) gave their informed consent and
were randomly assigned, by a computer-generated list, to
receive counselling alone (Group 1) or counselling together
with an occlusal splint (Group 2). The allocation of groups was
concealed and designated according to sequentially numbered,
opaque, sealed envelopes given to a person who did not know
the allocation sequence. Counselling involved verbal and
written information about TMD aetiology and prognostics, diet
modification in the sense of avoiding hard foods, use of
reminders to avoid parafunctional habits, relaxation techni-
ques of the jaw, application of a heating pad on painful muscles,
followed by stretching and self-massage, as well as sleep
hygiene and encouragement to practice social and aerobic
activities. In addition to the counselling cited above, Group 2
also received a full-coverage hard acrylic upper stabilization
appliance. This appliance was fabricated in a dental lab and
adjusted at chairside. The occlusal surface was smooth and flat,
2–2.5 mm thick in the posterior region, with an anterior
guidance occlusal scheme. Patients were instructed to wear
their splints only at night, while sleeping. The follow-up interval
was 5 months with three evaluation periods: baseline and after
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person, blinded to the group allocation.
2.3. Outcomes
The measured outcomes were symptoms of anxiety and
depression and pain catastrophizing.
Symptoms of anxiety and depression were measured
according to the Hospital Anxiety and Depression Scale
(HADS),19 a self-reported questionnaire consisting of 14 multi-
ple-choice questions involving two interspersed subscales, one
for anxiety (7 questions) and the other for depression (7
questions). The scores ranged from 0 to 21 points and were
divided into four categories: 0–7 (no anxiety or depression), 8–10
(mild anxiety or depression), 11–14 (moderate anxiety or
depression) and 15–21 (severe anxiety or depression).20,21 The
authors used the Brazilian Portuguese version, which shows
metric properties similar to those of the original version.19
The Catastrophizing Thoughts subscale of the Pain Related
Self-Statement Scale was used to measure pain catastrophiz-
ing.22 This subscale is also a self-reported questionnaire that
consists of 9 statements related to catastrophizing thoughts
involved in pain perception. The respondent was asked to
answer each statement indicating the frequency of thinking
about pain during a pain crisis, according to a 5-point scale.
The sum of all frequencies was divided by the total number of
questions. Higher values demonstrate higher levels of pain
catastrophizing. The authors used the Brazilian Portuguese
version, which shows adequate metric properties, with a
Cronbach alpha coefficient (Cronbach a) of 0.89 and the split-
half Pearson correlation of 0.74, demonstrating acceptable
internal consistency and correlation.23
2.4. Statistics
The pain catastrophizing values were expressed as a mean
and standard deviation (SD), along with a description of the
symptoms of anxiety and depression distribution. Prior to the
inferential analysis, the pain catastrophizing level was
assessed for normal distribution using the Kolmogorov–
Smirnov test.
The symptoms of anxiety and depression in all the
assessment periods were compared within and between
groups using the Friedman and Mann–Whitney test, consid-
ering a 5% significance level.
Two-way ANOVA, considering time as a repeated factor,
was performed to compare the pain catastrophizing values.
The significance level was set at 5%. The effect size of all the
significant results was calculated according to Cohen’s
coefficient (Cohen’s d), which scored the effect as small
(d = 0.2), moderate (d = 0.5) and large (d = 0.8).
Both groups were evaluated according to an intention-to-
treat analysis and the missing data for patients lost to follow-
up was handled by excluding the subjects from the analysis.
3. Results
The flow of the participants through the study is shown in
Fig. 1. Two hundred and thirty-six subjects were evaluated forpossible inclusion between August 2011 and November 2012.
One hundred and seventy-six did not meet the criteria. All
those fulfilling the inclusion conditions accepted the invita-
tion to participate. In Group 1, one subject requested an
occlusal splint and 3 subjects requested pharmacological
treatment in the second-month follow-up. In Group 2, one
subject requested pharmacological treatment and another
subject sought orthodontic treatment, also in the second-
month follow-up. Nevertheless, all participants whose data
was collected were analyzed according the groups to which
they were originally allocated. In the end, 13 participants in
Group 1 and 6 in Group 2 were lost to follow-up.
The baseline demographic characteristics of all enrolled
subjects were as follows: 90% were women in both groups,
with a mean (SD) age of 36 (6.6) for Group 1 and 27.7 (6.7) for
Group 2. The baseline values of all measured outcomes are
presented in Table 1. Sixty percent of the subjects had at least
mild anxiety and 25% had some degree of depression. Pain
catastrophizing values were 2.41 (1.33) for Group 1 and 2.06
(1.04) for Group 2. The randomization process ensured that
any baseline differences would be due to chance.
Figs. 2 and 3 show, respectively, the proportion of
symptoms of anxiety and depression throughout the treat-
ment. There was a significant reduction in anxiety and
depression only for Group 2 ( p < 0.05), in relation to the
baseline and the fifth-month evaluation. There were no
between-group differences.
Table 2 presents the pain catastrophizing values through-
out the treatment. There was a significant reduction in all
groups in relation to baseline and after the fifth-month
evaluation ( p < 0.05); nonetheless, this difference already
appeared after the 2nd month for Group 2. The effect size
(Cohen’s d) was higher in relation to the significant within-
group differences, and ranged from 0.74 to 1.33. There were no
between-group differences.
4. Discussion
This randomized controlled trial evaluated the effect of two
strategies for masticatory myofascial pain management on
the improvement of psychological aspects. Both null hypoth-
eses were rejected and the main findings were: (a) minimally
invasive strategies presented efficacy in improvement of
symptoms of anxiety, depression and pain catastrophizing
levels after 5 months; (b) although there were no between-
group differences, the use of counselling and self-manage-
ment therapy, in addition to an occlusal splint, presented an
earlier improvement in pain catastrophizing.
The sample demographic characteristics are similar to the
age and gender distribution of TMD muscle pain, i.e., middle-
aged women.24 Similarly, most of the samples had a degree of
anxiety and depression and a pain catastrophizing level
common to chronic pain patients.25–27 These findings rein-
force the association between psychological aspects and TMD.
The physiological background for the interaction between
pain and emotions is based on the overlap between neuronal
regions, like amygdala, periaqueductal grey matter (PAG) and
rostral ventral medulla, and neurotransmitters, like norepi-
nephrine and serotonin.3,28 Thus, changes in one circuitry
Fig. 1 – Diagram of the subjects throughout all study phases.
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and its direction could be difficult to establish. Evidence of
longitudinal studies addressing this issue shows that elevated
degrees of anxiety and depression, as well as higher painTable 1 – Baseline values of psychological characteristics





Anxiety symptoms, n (%)
Anxiety-free 12 (40%) 13 (43.3%)
Mild 6 (20%) 9 (30%)
Moderate 9 (30%) 6 (20%)
Severe 3 (10%) 2 (6.6%)
Depression symptoms, n (%)
Depression-free 20 (66.6%) 25 (83.3%)
Mild 5 (16.6%) 3 (10%)
Moderate 5 (16.6%) 1 (3.3%)
Severe 0 (0%) 1 (3.3%)
Pain catastrophizing mean
(standard deviation)
2.41 (1.33) 2.06 (1.04)catastrophizing levels, are predisposing factors for musculo-
skeletal pain.29 In relation to TMD, higher degree of stress,
anxiety and depression are considered predisposing factors.10
The role of emotions in pain perception is well estab-
lished.30 Negative emotional states are generally associated
with more severe clinical condition, or could adversely affect
the progression of chronic pain.31 Our questionnaire evaluated
the emotional state related to anxiety and depression, and
showed that pain management was able to modulate these
aspects positively. This difference was noted only when the
occlusal splint was combined with counselling; this could
indicate that occlusal devices offer an additional effect.
Pain catastrophizing is related to negative and amplified
thoughts involving a noxious stimulus and pain perception,
and this profile is associated with TMD onset.22,29 Our
results indicated the opposite direction, namely, that a
significant and relevant decrease in pain catastrophizing
could be an expected consequence of TMD management
focused on improving function and reducing pain intensity.
In addition, earlier improvement achieved when an occlu-
sal splint is added highlights the short-term impact of this
approach.
Fig. 2 – Anxiety symptoms in all evaluation periods.
Fig. 3 – Depression symptoms in all evaluation periods.
Table 2 – Mean (standard deviation) of pain catastro-
phizing values in all evaluation periods.
Baseline 2 months 5 months
Group 1 2.15 (1.42)a 1.54 (1.38)ab 1.14 (1.28)b
Group 2 2.06 (1.11)a 1.03 (1.03)b 0.76 (0.82)b
Different letters in the same row mean within-group differences.
There were no between group differences.
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that pain management strategies not primarily related to
psychosocial aspects have a positive effect on these same
aspects in subjects with musculoskeletal disorders.32 Never-
theless, counselling and self-management techniques were
used because they stimulate the subject to change his/her
behaviour and stress the importance of emotional self-control.
Therefore, we can argue that the improvement was
achieved as a result of specific counselling-related instruc-
tions. On the other hand, it can be assumed that the use of an
occlusal splint is capable of providing additional and earlier
benefits. This capability is borne out when assessing the
improvement in pain intensity and muscle tenderness.33
Accordingly, we can assert that the occlusal splint therapy is
effective as a behavioural intervention rather than as a purely
mechanical device and that its effects exceed those of
peripheral modifications in the masticatory system. Moreover,
our results support the theory of a psychological disorder
(anxiety, depression and higher pain catastrophizing) being a
consequence of masticatory myofascial pain, hence, indicat-
ing a bidirectional cause–effect relationship between pain and
psychosocial factors.34This study has some limitations that must be highlighted.
Although the psychological assessments were performed
through validated and reliable questionnaires,26,35 there was
no clinical evaluation. For this reason, we were unable to
diagnose emotional disorders, and could only suspect their
presence. We also presented no specific results for pain
intensity or muscle tenderness. Although the scope of this
study was not pain per se, any judgement about the efficacy of
TMD management must involve these aspects. Our counsel-
ling strategy included instructions related to psychological
aspects, but this strategy is not recognized as a psychological
treatment. In addition, the unequal between-group and
overall number of withdraws from the study could jeopardize
our results regarding group comparisons, but could also
suggest that the use of an occlusal splint is useful to increase
treatment adherence. Finally, the additional effect claimed by
occlusal splints remains to be confirmed, and more research is
needed to conduct further analysis, especially using a more
appropriate control group, e.g., no treatment or placebo splint.
We can thus conclude that minimally invasive strategies
for TMD management provide positive effects regarding the
improvement of psychological aspects in subjects with a chief
complaint of masticatory myofascial pain, and that the use of
an occlusal splint seems to hasten the manifestation of these
effects.
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